These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19854345)

  • 1. Development and validation of an HPLC method for the determination of process-related impurities in pridinol mesylate, employing experimental designs.
    Bianchini RM; Castellano PM; Kaufman TS
    Anal Chim Acta; 2009 Nov; 654(2):141-7. PubMed ID: 19854345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validated stability-indicating HPLC method for the determination of pridinol mesylate. Kinetics study of its degradation in acid medium.
    Bianchini RM; Castellano PM; Kaufman TS
    J Pharm Biomed Anal; 2008 Dec; 48(4):1151-60. PubMed ID: 18922659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Method development and validation for the simultaneous determination of meloxicam and pridinol mesylate using RP-HPLC and its application in drug formulations.
    Vignaduzzo SE; Castellano PM; Kaufman TS
    J Pharm Biomed Anal; 2008 Jan; 46(2):219-25. PubMed ID: 17961953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API.
    Kumar AP; Ganesh VR; Rao DV; Anil C; Rao BV; Hariharakrishnan VS; Suneetha A; Sundar BS
    J Pharm Biomed Anal; 2008 Mar; 46(4):792-8. PubMed ID: 18191357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC.
    Jing Q; Shen Y; Tang Y; Ren F; Yu X; Hou Z
    J Pharm Biomed Anal; 2006 Jun; 41(3):1065-9. PubMed ID: 16545536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation and estimation of process-related impurities of gefitinib by reverse-phase high-performance liquid chromatography.
    Chandrashekara KA; Udupi A; Reddy CG
    J Chromatogr Sci; 2014 Sep; 52(8):799-805. PubMed ID: 23897663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution.
    Kasawar GB; Farooqui M
    J Pharm Biomed Anal; 2010 May; 52(1):19-29. PubMed ID: 20045275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.
    Tan L; Wlasichuk KB; Schmidt DE; Campbell RL; Hirtzer P; Cheng L; Karr DE
    J Pharm Biomed Anal; 2012 Jul; 66():75-84. PubMed ID: 22459505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Validated RP-HPLC Method for the Analysis of 1-Fluoronaphthalene and Its Process-Related Impurities.
    Karagiannidou EG; Bekiari ET; Vastardi EI
    J Chromatogr Sci; 2015 Sep; 53(8):1296-302. PubMed ID: 25713107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New gradient high-performance liquid chromatography method for determination of donepezil hydrochloride assay and impurities content in oral pharmaceutical formulation.
    Kafkala S; Matthaiou S; Alexaki P; Abatzis M; Bartzeliotis A; Katsiabani M
    J Chromatogr A; 2008 May; 1189(1-2):392-7. PubMed ID: 18206895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a reversed phase liquid chromatographic method for analysis of oxytetracycline and related impurities.
    Kahsay G; Shraim F; Villatte P; Rotger J; Cassus-Coussère C; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2013 Mar; 75():199-206. PubMed ID: 23277151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a high-performance liquid chromatographic method for the simultaneous determination of tramadol and its impurities in oral drops as a pharmaceutical formulation.
    Zecević M; Stanković Z; Zivanović Lj; Jocić B
    J Chromatogr A; 2006 Jun; 1119(1-2):251-6. PubMed ID: 16386751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using an innovative Quality-by-Design approach for development of a stability indicating UHPLC method for ebastine in the API and pharmaceutical formulations.
    Schmidt AH; Molnár I
    J Pharm Biomed Anal; 2013 May; 78-79():65-74. PubMed ID: 23454599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation and determination of synthetic impurities of difloxacin by reversed-phase high-performance liquid chromatography.
    Rao RN; Nagaraju V
    J Pharm Biomed Anal; 2004 Nov; 36(4):729-35. PubMed ID: 15533664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a liquid chromatographic method for the simultaneous determination of aniracetam and its related substances in the bulk drug and a tablet formulation.
    Papandreou G; Zorpas K; Archontaki H
    J Pharm Biomed Anal; 2011 Nov; 56(3):615-22. PubMed ID: 21742456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of chromatographic methods for the determination of genotoxic impurities in cloperastine fendizoate.
    García A; Rupérez FJ; Ceppa F; Pellati F; Barbas C
    J Pharm Biomed Anal; 2012 Mar; 61():230-6. PubMed ID: 22226040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
    Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
    J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
    El Karbane M; Azougagh M; Amood A L-Kamarany M; Bouchafra H; Cherrah Y; Bouklouze A
    Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC determination of glimepiride and its related impurities.
    Khan MA; Sinha S; Vartak S; Bhartiya A; Kumar S
    J Pharm Biomed Anal; 2005 Oct; 39(5):928-43. PubMed ID: 16040224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A validated RP-HPLC method for quantitative determination of related impurities of ursodeoxycholic acid (API) by refractive index detection.
    Peepliwal A; Bonde CG; Bothara KG
    J Pharm Biomed Anal; 2011 Mar; 54(4):845-9. PubMed ID: 21095088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.